A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Please provide your email address to receive an email when new articles are posted on . In 2020, the global lifetime risk for developing and dying from gastrointestinal cancers was 8.2% and 6.17%.

Tiago Biachi, MD, PhD, highlighted the transformative role of personalized medicine in gastrointestinal (GI) cancer treatment through advances in next-generation sequencing and circulating tumor DNA, ...

Investigators sought to determine when malnutrition appears in patients with GI cancer and how nutritional status affects quality of life and fatigue during treatment.

The liver is an extremely sensitive organ. It filters blood, eliminates toxins and creates bile to digest food; without a functioning liver, a person will die. Its sensitive nature, however, makes it ...

More than 1 in 5 of new gastrointestinal (GI) cancer cases globally were attributable to suboptimal dietary intake, according to a recent study. Writing in Gastroenterology, researchers led by Li Liu, ...

Early-onset gastrointestinal cancers represent the most rapidly increasing early-onset cancer in the U.S. Colorectal cancer is the most common early-onset GI cancer, but pancreatic, gastric, and ...

Gastrointestinal cancer represents a complex group of diseases that affect the digestive system, claiming hundreds of thousands of lives globally each year. These malignancies can develop anywhere ...

A recent study has identified a potential new tool to help detect gastrointestinal cancers — the platelet-to-high-density lipoprotein ratio, or PHR. Researchers analyzed data from more than 19,000 ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. John Gaetano performs a colonoscopy on Mike Lowe, 45, at Northwestern Lake Forest Hospital on April 18. (Stacey Wescott / ...

ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...